The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people

BJ Sahakian, AB Bruhl, J Cook… - … of the Royal …, 2015 - royalsocietypublishing.org
In addition to causing distress and disability to the individual, neuropsychiatric disorders are
also extremely expensive to society and governments. These disorders are both common …

The prefrontal cortex achieves inhibitory control by facilitating subcortical motor pathway connectivity

CL Rae, LE Hughes, MC Anderson… - Journal of …, 2015 - Soc Neuroscience
Communication between the prefrontal cortex and subcortical nuclei underpins the control
and inhibition of behavior. However, the interactions in such pathways remain controversial …

Dopaminergic modulation of motor network dynamics in Parkinson's disease

J Michely, LJ Volz, MT Barbe, F Hoffstaedter… - Brain, 2015 - academic.oup.com
Although characteristic motor symptoms of Parkinson's disease such as bradykinesia
typically improve under dopaminergic medication, deficits in higher motor control are less …

Therapeutic strategies in Parkinson's disease: what we have learned from animal models

JS Valadas, M Vos, P Verstreken - … of the New York Academy of …, 2015 - Wiley Online Library
Parkinson's disease (PD), the second most common neurodegenerative disorder, is
characterized by a loss of dopaminergic neurons in the substantia nigra, as well as in other …

Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals

H Fox, M Sofuoglu, R Sinha - Journal of …, 2015 - journals.sagepub.com
Objectives: Attenuation of adrenergic drive and cognitive enhancement, via stimulation of
alpha2 pre-and post-synaptic receptors, may selectively enhance executive performance in …

Monoamine reuptake inhibitors in Parkinson's disease

P Huot, SH Fox, JM Brotchie - Parkinson's Disease, 2015 - Wiley Online Library
The motor manifestations of Parkinson's disease (PD) are secondary to a dopamine
deficiency in the striatum. However, the degenerative process in PD is not limited to the …

Developments in impulse control behaviours of Parkinson's disease

M Zurowski, JD O'Brien - Current opinion in neurology, 2015 - journals.lww.com
Reduction of dopamine agonist dose is the mainstay of treatment of ICBs. Other forms of
dopaminergic treatment such as deep brain stimulation or jejunal infusion are alternative …

[PDF][PDF] (Dis) Inhibition Imaging Neuropsychiatry in Parkinson's disease

C Vriend - 2015 - research.vumc.nl
Up to 50 percent of all Parkinson's disease (PD) patients develop symptoms of anxiety
during the course of their illness, a percentage that is much higher than in the general …